SMARCA2 and renal cell carcinoma: Additionally, NSUN2 reportedly promotes multiple cancer progression.[24, 36] We observed that NSUN2 was distributed mainly in the nucleus of tumor cells in multiple BrM subtypes but was rarely detected in BrM (RCC), suggesting that NSUN2 may be implicated in specific subtypes of BrMs rather than all tumor types.